Key takeaways:

The FDA said it will send letters to pharmaceutical companies asking for the removal of “misleading” drug ads.

The agency also plans to send out cease-and-desist letters to drug companies with “deceptive” ads.

President Donald J. Trump signed a new memorandum that aims to crack down on “misleading” direct-to-consumer pharmaceutical advertisements.

On Sept. 9, Trump issued a memorandum to HHS Secretary Robert F. Kennedy Jr . requesting that the FDA take “appropriate action to ensure transparency and accuracy in direct-to-consumer prescription drug advertising.”

The FDA announced it plans to crackdown on direct-to-consumer pharmaceutical advertising that contains "misleading" information.

“The FDA has historically stipulated that a manufacturer, packer or distributor

See Full Page